Ogino M
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Jun;38(6):817-26.
Neither urinary plasmin-activity nor whole plasmin changed during the menstrual period of healthy women. Among Japanese women, pill-takers' recorded a markedly higher level of plasmin-activity than non-takers. No such trend was observed with whole plasmin and FDP. Among American women, no significant difference between non-users and users concerning the levels of whole plasmin, plasmin activity and FDP was observed. Among Japanese women, a significantly high level of plasmin activity was observed after administering pills for one year. Five out of six rabbits treated with thrombin intramuscularly showed a level of urinary plasmin activity which is five times higher than the control. The number of platelets decreased in two rabbits, the amounts of fibrinogen in one, and prothrombin time in one. Plasmin activity did not change in rabbits treated with 1/20 X and 1 X maximal tolerated dose (MTD) of norethisterone and mestranol, but was significantly increased by 50 X MTD of norethisterone and mestranol. On the other hand, when treated with both norethisterone and mestranol, plasmin activity did not change with 1/20 X but significantly increased with 1 X and 50 X. The activity of plasminogen activator in glomeruli of rats was increased dose-dependently by thrombin. However, norethisterone, mestranol, and norethisterone-mestranol failed to activate production of plasminogen activator. In conclusion, looking at the comparison of the fibrinolytic system of American and Japanese women, the fibrinolytic system in endothelial cells was found to react well to thrombin among Japanese but weakly among Americans. The weak reaction of the fibrinolytic system among Americans is suggested to be a cause of the increase in thrombosis.
健康女性月经期间尿纤溶酶活性和全纤溶酶均无变化。在日本女性中,服用避孕药者的纤溶酶活性水平明显高于未服用者。全纤溶酶和纤维蛋白降解产物(FDP)未观察到此类趋势。在美国女性中,未使用者和使用者在全纤溶酶、纤溶酶活性和FDP水平方面未观察到显著差异。在日本女性中,服用避孕药一年后观察到纤溶酶活性显著升高。六只经肌肉注射凝血酶处理的兔子中有五只尿纤溶酶活性水平比对照组高五倍。两只兔子的血小板数量减少,一只兔子的纤维蛋白原量减少,一只兔子的凝血酶原时间延长。用炔诺酮和炔雌醇1/20倍最大耐受剂量(MTD)和1倍MTD处理的兔子纤溶酶活性未变化,但用炔诺酮和炔雌醇50倍MTD处理后纤溶酶活性显著升高。另一方面,同时用炔诺酮和炔雌醇处理时,1/20倍剂量时纤溶酶活性未变化,但1倍和50倍剂量时显著升高。凝血酶可使大鼠肾小球中纤溶酶原激活物的活性呈剂量依赖性增加。然而,炔诺酮、炔雌醇以及炔诺酮 - 炔雌醇未能激活纤溶酶原激活物的产生。总之,对比美国和日本女性的纤溶系统发现,日本女性内皮细胞中的纤溶系统对凝血酶反应良好,而美国女性则较弱。美国女性纤溶系统的弱反应被认为是血栓形成增加的一个原因。